top of page

OUR TEAM

With passion and a wealth of experience, our leadership team is committed to the development of innovative therapies, the creation of new business models, and driving high-value strategic collaborations.

Core Management Team

CEO Amy Huang

Amy Huang
CEO, Founder

Ms. Huang previously served as Vice President at Taian Biotechnology Co., Ltd., bringing a background as a seasoned venture capital fund manager with exceptional insight into innovative technologies. Her investment expertise spans a wide range of areas, including novel drug development, pharmaceutical formulations, biosimilars, API manufacturing, medical devices, and diverse disease fields such as neurodegeneration, diabetes, oncology, precision medicine, inflammation, and infection.

 

Leveraging her professional strategic planning capabilities, Ms. Huang has successfully led numerous portfolio companies through significant milestones, including financing, strategic partnerships, scaling operations, and corporate transformations. 


Currently, she is responsible for corporate management strategic planning, innovative technology development, organizational structure design and optimization, and overseeing external business development and collaborations, all with the aim of driving the company's robust growth and sustainable development. As the founder of our company, Ms. Huang further guides us towards new horizons with her long-term vision and unwavering conviction.

Scientific & Administrative Team

Scientific Advisors

Ph.D. in Statistics from the University of Minnesota
Fellow of the American Statistical Association
Founder of the Department of Biostatistics at Rutgers New Jersey Medical School
Adjunct Director of Biostatistics in Cancer Research at Rutgers New Jersey Medical School
Consultant to the U.S. Department of Health and Human Services
Early promoter and lifetime member of the Pan-Pacific Association of Quantitative Methods
Pioneer in the "sample size re-estimation" method, advocating for its use in achieving "consistency"
Author of statistical principles for testing "bridging trials"
Honorary retired professor at Rutgers University since 2020

bottom of page